Antero Horte
Papers
3
Total Citations
58
H-Index
3
About
Antero Horte is a leading figure in the advancement of minimally invasive treatments for prostate cancer, with a particular focus on MRI-guided interventions and surgical quality. His research centers on the development and evaluation of MRI-guided transurethral ultrasound ablation (TULSA) as a precise, organ-sparing therapy for localized prostate cancer. Horte’s most cited work, a feasibility study on lesion-targeted TULSA (30 citations), established the safety and accuracy of this emerging technique, demonstrating its potential to ablate tumors while preserving healthy tissue. He further characterized the acute and subacute MRI findings following TULSA, providing critical imaging biomarkers for treatment assessment. Beyond ablation, Horte has significantly impacted surgical practice through his analysis of robot-assisted radical prostatectomy adoption in Finland (20 citations), revealing how centralization of care improved quality metrics and patient outcomes. His contributions bridge cutting-edge ablation technology with real-world surgical quality improvement, making him a key voice in modern prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3